Study guide

6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting

AMT Medical Laboratory Scientist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: General Laboratory Operations, Safety & Quality

1.1 Laboratory Safety, OSHA Standards, Hazard Communication, and Biohazard Control 1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation 1.3 Specimen Collection, Handling, Order of Draw, and Phlebotomy Complications 1.4 Laboratory Instrumentation, Photometry, Spectrophotometry, and Centrifugation 1.5 Laboratory Mathematics, Dilutions, Solution Preparation, and Standard Curves 1.6 Regulatory Compliance, CLIA '88 Regulations, Accreditation, and Laboratory Ethics

2 Chapter 2: Clinical Chemistry & Metabolic Testing

2.1 Carbohydrate Metabolism, Glucose Regulation, Diabetes Mellitus, and HbA1c 2.2 Proteins, Non-Protein Nitrogenous Compounds (BUN, Creatinine, Uric Acid), and Renal Function 2.3 Enzymology and Organ Systems 2.4 Electrolytes, Acid-Base Balance, Anion Gap, and Blood Gas Analysis 2.5 Clinical Endocrinology, Thyroid, Adrenal, and Reproductive Hormones 2.6 Clinical Toxicology, Therapeutic Drug Monitoring (TDM), and Pharmacokinetics 2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation

3 Chapter 3: Hematology & Leukocyte Disorders

3.1 RBC Indices and Anemia 3.2 WBC Differential and Benign Disorders 3.3 Hematologic Malignancies 3.4 Hemoglobin Structure, Hemoglobinopathies (Sickle Cell, Thalassemia), and Variants 3.5 Hematology Automation, Flow Cytometry, and Cell Counting Technology

4 Chapter 4: Coagulation & Hemostasis

4.1 Primary and Secondary Hemostasis, Platelet Function, and Vascular Integrity 4.2 Coagulation Cascade Disorders 4.3 Coagulation Testing and Anticoagulants

5 Chapter 5: Immunology & Serology

5.1 Immune Mechanisms, Hypersensitivity Reactions, and Autoimmune Disease Testing 5.2 Serological Testing Principles and Infectious Serology

6 Chapter 6: Immunohematology & Blood Grouping

6.1 ABO and Rh Blood Group Systems, Antigens, Subgroups, and Weak D Variant 6.2 Red Cell Antibody Screening, Identification Panels, and Dosage Effects 6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting 6.4 Compatibility Testing, Crossmatching, and Hemolytic Disease of the Fetus and Newborn

7 Chapter 7: Blood Banking & Transfusion Medicine

7.1 Blood Donor Selection, Screening, Collection, and Component Storage 7.2 Transfusion Practice, Indications for Blood Components, and Administration 7.3 Transfusion Reactions: Investigation Protocol and Reaction Classification

8 Chapter 8: Clinical Microbiology

8.1 Specimen Processing, Gram Stain, and Aerobic Gram-Positive Cocci 8.2 Gram-Negative Bacilli: Enterobacteriaceae, Non-Fermenters, and Fastidious Organisms 8.3 Anaerobic Bacteria, Mycobacteria, Acid-Fast Stains, and Molecular Diagnostic Methods 8.4 Clinical Mycology and Medical Parasitology 8.5 Antimicrobial Susceptibility Testing, Resistance, and Virology

9 Chapter 9: Urinalysis & Body Fluids

9.1 Physical and Chemical Examination of Urine and Reagent Strip Principles 9.2 Microscopic Urinalysis: Cells, Casts, Crystals, and Renal Pathology 9.3 Analysis of Cerebrospinal Fluid (CSF), Serous Fluids, and Synovial Fluid

6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting

Key Takeaways Explain This Topic AI

The Direct Antiglobulin Test (DAT) detects in vivo sensitization of red blood cells by IgG and/or complement.

The Indirect Antiglobulin Test (IAT) detects in vitro sensitization and is the underlying principle for antibody screens and AHG crossmatches.

Inadequate washing is the most common cause of false-negative AHG tests due to unbound globulins neutralizing the AHG reagent.

Coombs Control Cells (Check Cells) must be added to all negative AHG tubes to validate the test system; a positive macroscopic reaction is required.

Last updated: July 2026

  • 6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting
  • The Principle of the Antiglobulin Test

Developed in the 1940s by Robin Coombs, the antiglobulin test revolutionized blood banking by enabling the detection of "incomplete" antibodies. IgG antibodies are relatively small monomers that can attach to specific antigens on red blood cell membranes but cannot span the physical distance (zeta potential) between two red cells to cause visible agglutination.

To visualize this binding, Anti-Human Globulin (AHG) reagent is utilized. AHG contains antibodies directed against human IgG and/or human complement fragments (C3d). When added to sensitized red cells, AHG forms physical cross-links between the attached IgG molecules, resulting in macroscopic lattice formation (agglutination).

Direct Antiglobulin Test (DAT)

The DAT is designed to detect in vivo sensitization —meaning the red blood cells were coated with antibodies or complement while actively circulating inside the patient's body.

DAT Procedure

Because the cells are already coated, no incubation is required.

Obtain patient red cells (ideally drawn in an EDTA tube to chelate calcium and prevent in vitro complement attachment).

Wash the cells 3-4 times with saline to meticulously remove all unbound plasma proteins.

Add polyspecific AHG reagent directly to the washed cell button.

Centrifuge and examine for agglutination.

Clinical Indications for a DAT

A positive DAT points to active immune destruction of red cells:

Hemolytic Disease of the Fetus and Newborn (HDFN) : Maternal IgG crosses the placenta and coats the fetal RBCs.

Hemolytic Transfusion Reaction (HTR) : The patient's alloantibodies coat the newly transfused donor RBCs.

Autoimmune Hemolytic Anemia (AIHA) : The patient produces autoantibodies against their own red cell antigens (e.g., Warm AIHA, Cold Agglutinin Disease).

Drug-Induced Hemolytic Anemia : Medications like penicillin, cephalosporins, or methyldopa alter the red cell membrane or form immune complexes that coat the RBC.

If the initial DAT using polyspecific AHG is positive, a differential DAT is performed using monospecific Anti-IgG and monospecific Anti-C3d to precisely identify the coating proteins.

Indirect Antiglobulin Test (IAT)

The IAT detects in vitro sensitization —identifying antibodies present in the patient's serum or plasma that attach to red cells only during a controlled laboratory incubation.

IAT Procedure

Mix patient serum/plasma with specific reagent red cells.

Incubate at 37°C for a defined time (usually 15-60 minutes depending on the potentiator) to allow antibody attachment.

Wash the cells 3-4 times with saline.

Add AHG reagent, centrifuge, and read for agglutination.

Clinical Applications of the IAT

The IAT principle is the foundation for several critical procedures:

Antibody Screening and Identification : Testing patient serum against known O cells to detect alloantibodies.

Major Crossmatching : Testing patient serum against donor red cells at the AHG phase to ensure full serologic compatibility.

Antigen Typing : Testing patient red cells with commercial antisera that require an AHG phase to read (e.g., Kell or Weak D typing).

Coombs Control Cells (Check Cells)

To ensure quality control and prevent fatal reporting errors, Coombs Control Cells (Group O positive red cells intentionally coated with IgG) are added to every tube that tests negative at the AHG phase.

After adding the check cells and centrifuging, the reaction must be positive (typically a 2+ to 3+ agglutination). This mandatory positive result verifies three things:

AHG reagent was actually dispensed into the tube.

The AHG reagent was active and functional.

The washing phase was completely successful, and the AHG was not neutralized by unbound proteins.

If the check cells do not agglutinate, the entire test is deemed invalid and must be repeated from the beginning.

Troubleshooting Serologic Errors

Blood bank technologists must rapidly identify and correct procedural errors.

Error Category Specific Cause Resulting Error Explanation

False Negative Inadequate washing AHG neutralization Unbound globulins remain in the tube, binding to and completely neutralizing the AHG reagent before it can cross-link the RBCs.

False Negative Delay in adding AHG Elution of antibody Bound IgG dissociates from the red cells during a prolonged delay after washing.

False Negative Failure to add AHG No cross-linking The lattice reaction cannot occur without the cross-linking reagent.

False Positive Over-centrifugation Mechanical clumping Red cells form an excessively tight button that mimics true agglutination when resuspended.

False Positive Contaminated saline Spontaneous agglutination Bacterial, heavy metal, or silica contamination causes non-specific cellular aggregation.

False Positive Fibrin interference Fibrin strands Serum from incompletely clotted specimens creates fibrin networks trapping RBCs, mimicking a positive reaction.

Exam Trap: The singular most common cause of a false-negative AHG test is inadequate washing . This error is instantly identified when the subsequent addition of check cells yields a negative result.